- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
PYC Therapeutics Ltd (PYC)
PYC Therapeutics Ltd stock price live, this page displays ASX PYC stock exchange data. View the PYC premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the PYC Therapeutics Ltd real time stock price chart below.
What Is the PYC Therapeutics Ltd Stock Price Today?
The PYC Therapeutics Ltd stock price today is 1.350.
What Is the Stock Symbol for PYC Therapeutics Ltd?
The stock symbol for PYC Therapeutics Ltd is ""PYC.""
What Stock Exchange Does PYC Therapeutics Ltd Trade On?
PYC Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is PYC Therapeutics Ltd a Good Stock to Buy?
Determining whether PYC Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PYC quote. (ISIN: AU000000PYC7)
What Is the PYC Therapeutics Ltd Stock Price Today?
The PYC Therapeutics Ltd stock price today is 1.350.
What Is the Stock Symbol for PYC Therapeutics Ltd?
The stock symbol for PYC Therapeutics Ltd is ""PYC.""
What Stock Exchange Does PYC Therapeutics Ltd Trade On?
PYC Therapeutics Ltd is listed and trades on the Sydney stock exchange.
Is PYC Therapeutics Ltd a Good Stock to Buy?
Determining whether PYC Therapeutics Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PYC quote. (ISIN: AU000000PYC7)
Sydney
Currency in AUD
1.350
+0.015(+1.12%)
Closed·
Fair Value
An estimate of a PYC Therapeutics Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.315
1.360
52 wk Range
0.950
2.089
PYC Scorecard
Full Analysis
Net income is expected to drop this year
PYC is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a PYC Therapeutics Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.3151.360
52 wk Range
0.9502.089
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PYC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a PYC Therapeutics Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
3.417
Upside
+153.09%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
PYC Therapeutics Ltd Company Profile
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program which is Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for the treatment of blinding eye disease; PYC-002 a drug program for the treatment of a severe neurodevelopmental disorder; and PYC-003, which is indicated to treat autosomal dominant polycystic kidney disease. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.
PYC Therapeutics Ltd Earnings Call Summary for Q2/2025
- PYC Therapeutics focused on advancing four key pipeline assets: RP11, ADOA, PKD, and Phelan McDermott Syndrome
- Company exploring non-dilutive funding through out-licensing, maintaining strong liquidity with a current ratio of 4.77
- Targeting three mid to late-stage clinical studies by end of 2024; RP11 registrational study estimated at $60 million
- Stock closed at $1.22, up 1.67%; company faces profitability challenges with negative EBITDA of $0.84M in last 12 months
- Human efficacy readouts expected within 12 months, potentially impacting market position amid challenging macro environment
Last Updated: 30/05/2025, 02:28
Read Full TranscriptCompare PYC to Peers and Sector
Metrics to compare | PYC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPYCPeersSector | |
|---|---|---|---|---|
P/E Ratio | −16.3x | −4.2x | −0.5x | |
PEG Ratio | 0.21 | −0.02 | 0.00 | |
Price/Book | 14.2x | 2.1x | 2.6x | |
Price / LTM Sales | 31.5x | 7.9x | 3.3x | |
Upside (Analyst Target) | 162.2% | 330.6% | 41.6% | |
Fair Value Upside | Unlock | −0.1% | 5.9% | Unlock |
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 3.417
(+153.09% Upside)
Earnings
Latest Release
Feb 27, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
11.84M / --
FAQ
What Stock Exchange Does PYC Therapeutics Ltd Trade On?
PYC Therapeutics Ltd is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for PYC Therapeutics Ltd?
The stock symbol for PYC Therapeutics Ltd is "PYC."
What Is the PYC Therapeutics Ltd Market Cap?
As of today, PYC Therapeutics Ltd market cap is 781.57M.
What Is PYC Therapeutics Ltd's Earnings Per Share (TTM)?
The PYC Therapeutics Ltd EPS (TTM) is -0.11.
From a Technical Analysis Perspective, Is PYC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has PYC Therapeutics Ltd Stock Split?
PYC Therapeutics Ltd has split 6 times.
How Many Employees Does PYC Therapeutics Ltd Have?
PYC Therapeutics Ltd has 5 employees.
What is the current trading status of PYC Therapeutics Ltd (PYC)?
As of 13 Aug 2025, PYC Therapeutics Ltd (PYC) is trading at a price of 1.35, with a previous close of 1.34. The stock has fluctuated within a day range of 1.32 to 1.36, while its 52-week range spans from 0.95 to 2.09.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.